First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.

Detalles Bibliográficos
Autores principales: Zhang, Xuhan, Song, Kaidi, Tong, Fei, Fei, Mingming, Guo, Hui, Lu, Zhaohui, Wang, Jinquan, Zheng, Changcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160284/
https://www.ncbi.nlm.nih.gov/pubmed/32243501
http://dx.doi.org/10.1182/bloodadvances.2020001907
Descripción
Sumario:We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.

Ejemplares similares